Y-Intercept (HK)’s Atea Pharmaceuticals AVIR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-28,882	Closed	-$108K	–	1059
2023 Q2	$108K	Buy	+28,882	New	+$108K	0.01%	1079
2021 Q4	–	Sell	-8,270	Closed	-$290K	–	575
2021 Q3	$290K	Buy	+8,270	New	+$290K	0.05%	472